logo

Shariatga muvofiqlik sharhi

Halol

Cerus Corporation (CERS) hozirda Akinda shariat skriningi (AAOIFI) bo'yicha Halol deb tasniflanadi.

Cerus Corporation haqida

Cerus Corporation operates as a biotechnology firm dedicated to advancing and marketing the INTERCEPT Blood System. This proprietary technology significantly enhances the safety of transfusable blood components by neutralizing biological threats, thereby reducing the risk of blood-borne pathogens.

Cerus Corporation (CERS) Healthcare sektorida, Medical - Devices sohasida faoliyat yuritadi.

Nega halol: aksiya AAOIFI ning uchala tekshiruvidan o'tadi. Nomuvofiq daromad — 0.00% (chegara 5%), foizli qarz — 24.51% (chegara 30%), foizli qimmatli qog'ozlar va aktivlar — 24.22% (chegara 30%).

Kompaniya faoliyati
0.00%Chegara 5%Muvaffaq
Foizli qarz
24.51%Chegara 30%Muvaffaq
Foizli qimmatli qog‘ozlar va aktivlar
24.22%Chegara 30%Muvaffaq
Dividendlarni poklash
0.00%Xayriyaga beriladigan dividend ulushiPoklash kalkulyatori

Oxirgi yangilanish: 23-okt, 2026 · Skrining ma'lumot uchun; bu fatvo emas. Shaxsiy maslahat uchun malakali olim bilan maslahatlashing.

CERS stock chart by TradingView

Kontentni ko'rish uchun tizimga kiring

Asosiy ko'rsatkichlar

Kontentni ko'rish uchun tizimga kiring

Kontentni ko'rish uchun tizimga kiring

Kompaniya profili

Kontentni ko'rish uchun tizimga kiring

Tez-tez beriladigan savollar

Cerus Corporation (CERS) bo‘yicha qisqa javoblar. Akinda skrining yorlig‘i: Halol.

Healthcare sektoridagi boshqa halol aksiyalar